Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yoko Shinagawa-Kobayashi"'
Autor:
Takuro Nagoya, Kenya Kamimura, Ryo Goto, Yoko Shinagawa‐Kobayashi, Yusuke Niwa, Atsushi Kimura, Norihiro Sakai, Masayoshi Ko, Hiroshi Nishina, Shuji Terai
Publikováno v:
FEBS Open Bio, Vol 9, Iss 12, Pp 2016-2024 (2019)
The effect of sodium‐glucose cotransporter 2 inhibitor (SGLT2I) on nonalcoholic steatohepatitis (NASH) has been reported, but there are few studies on its effect on NASH‐related renal injury. In this study, we examined the effect of SGLT2I using
Externí odkaz:
https://doaj.org/article/5f67ccb126194dc2a660a23af8500be7
Autor:
Ryo Goto, Kenya Kamimura, Yoko Shinagawa‐Kobayashi, Norihiro Sakai, Takuro Nagoya, Yusuke Niwa, Masayoshi Ko, Kohei Ogawa, Ryosuke Inoue, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Satoshi Abe, Hiroshi Nishina, Shuji Terai
Publikováno v:
FEBS Open Bio, Vol 9, Iss 4, Pp 643-652 (2019)
The rise in the incidence of nonalcoholic steatohepatitis (NASH) has necessitated the development of an effective prevention methodology. An antidiabetic drug, belonging to the group of sodium glucose cotransporter 2 (SGLT2) inhibitors, has been test
Externí odkaz:
https://doaj.org/article/e3afa94b88344eed9fd838e18dbfc43a
Autor:
Yuji Kobayashi, Kenya Kamimura, Hiroyuki Abe, Takeshi Yokoo, Kohei Ogawa, Yoko Shinagawa-Kobayashi, Ryo Goto, Ryosuke Inoue, Masato Ohtsuka, Hiromi Miura, Tsutomu Kanefuji, Takeshi Suda, Masanori Tsuchida, Yutaka Aoyagi, Guisheng Zhang, Dexi Liu, Shuji Terai
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
Hydrodynamic gene delivery is a common method for gene transfer to the liver of small animals, and its clinical applicability in large animals has been demonstrated. Previous studies focused on functional analyses of therapeutic genes in animals with
Externí odkaz:
https://doaj.org/article/bd47aac2c9bc46bd8ee49e0bb643f102
Autor:
Atsushi Kimura, Kenya Kamimura, Marina Ohkoshi-Yamada, Yoko Shinagawa-Kobayashi, Ryo Goto, Takashi Owaki, Chiyumi Oda, Osamu Shibata, Shinichi Morita, Norihiro Sakai, Hiroyuki Abe, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Shuji Terai
Publikováno v:
Biochemical and Biophysical Research Communications. 596:76-82
Nonalcoholic steatohepatitis (NASH) is a disease entity with an increasing incidence, with involvement of several metabolic pathways. Various organs, including the liver, kidneys, and the vasculature, are damaged in NASH, indicating the urgent need t
Autor:
Kenya Kamimura, Hiroshi Nishina, Atsushi Kimura, Ryo Goto, Masayoshi Ko, Yusuke Niwa, Shuji Terai, Takuro Nagoya, Yoko Shinagawa-Kobayashi, Norihiro Sakai
Publikováno v:
FEBS Open Bio
FEBS Open Bio, Vol 9, Iss 12, Pp 2016-2024 (2019)
FEBS Open Bio, Vol 9, Iss 12, Pp 2016-2024 (2019)
The effect of sodium‐glucose cotransporter 2 inhibitor (SGLT2I) on nonalcoholic steatohepatitis (NASH) has been reported, but there are few studies on its effect on NASH‐related renal injury. In this study, we examined the effect of SGLT2I using
Autor:
Ryo Goto, Satoshi Abe, Kohei Ogawa, Isao Sakaida, Takuro Nagoya, Yoshizu Nozawa, Soichi Sugitani, Akira Sakamaki, Koichi Fujisawa, Makoto Furutani-Seiki, Yoko Shinagawa-Kobayashi, Norihiro Sakai, Kenya Kamimura, Ryosuke Inoue, Naoto Koyama, Shuji Terai, Takeshi Yokoo, Masahiko Yanagi, Hiroshi Nishina
Publikováno v:
Biochemical and Biophysical Research Communications. 496:556-561
Background Sorafenib (SFN) is an anti-angiogenic chemotherapeutic that prolongs survival of patients with hepatocellular carcinoma (HCC); its side effects, including vascular damages such as hand-foot syndrome (HFS), are a major cause of therapy disc
Autor:
Kohei Ogawa, Akira Sakamaki, Takuro Nagoya, Yoko Shinagawa-Kobayashi, Hiroshi Nishina, Norihiro Sakai, Satoshi Abe, Kenya Kamimura, Ryosuke Inoue, Yukari Watanabe-Mori, Hiroteru Kamimura, Ryo Goto, Norio Miyamura, Shuji Terai, Takeshi Yokoo
Publikováno v:
FEBS Open Bio
The development of therapeutic options to promote hepatic regeneration following severe liver injury is essential. While humoral factors have been reported as mechanisms of liver regeneration, the contributions of interorgan communication to liver re
Autor:
Yusuke Niwa, Yoko Shinagawa-Kobayashi, Masayoshi Ko, Masahiko Yanagi, Norihiro Sakai, Takuro Nagoya, Satoshi Abe, Takeshi Yokoo, Kenya Kamimura, Soichi Sugitani, Toru Setsu, Hiroteru Kamimura, Akira Sakamaki, Shuji Terai
Publikováno v:
Cancer Management and Research
Norihiro Sakai,1,* Kenya Kamimura,1,* Yoko Shinagawa-Kobayashi,1 Takuro Nagoya,1 Yusuke Niwa,1 Masayoshi Ko,1 Toru Setsu,1 Akira Sakamaki,1 Takeshi Yokoo,1 Satoshi Abe,1 Hiroteru Kamimura,1 Soichi Sugitani,2 Masahiko Yanagi,3 Shuji Terai11Division of
Autor:
Ryo Goto, Masayoshi Ko, Satoshi Abe, Hiroshi Nishina, Kenya Kamimura, Ryosuke Inoue, Takeshi Yokoo, Takuro Nagoya, Shuji Terai, Akira Sakamaki, Kohei Ogawa, Yoko Shinagawa-Kobayashi, Norihiro Sakai, Yusuke Niwa, Hiroteru Kamimura
Publikováno v:
FEBS Open Bio
The rise in the incidence of nonalcoholic steatohepatitis (NASH) has necessitated the development of an effective prevention methodology. An antidiabetic drug, belonging to the group of sodium glucose cotransporter 2 (SGLT2) inhibitors, has been test
Autor:
Satoshi Abe, Takeshi Suda, Yoko Shinagawa-Kobayashi, Hiroteru Kamimura, Ryo Goto, Akira Sakamaki, Kenya Kamimura, Hiroshi Baba, Shuji Terai, Kohei Ogawa, Satoshi Yamagiwa, Takayuki Tanaka, Yutaka Aoyagi, Yoshizu Nozawa, Naoto Koyama, Takeshi Yokoo, Masaaki Takamura, Hirokazu Kawai
Publikováno v:
Cancer Management and Research
Kenya Kamimura,1 Yoko Shinagawa-Kobayashi,1 Ryo Goto,1 Kohei Ogawa,1 Takeshi Yokoo,1 Akira Sakamaki,1 Satoshi Abe,1 Hiroteru Kamimura,1 Takeshi Suda,2 Hiroshi Baba,3 Takayuki Tanaka,4 Yoshizu Nozawa,5 Naoto Koyama,6 Masaaki Takamura,1 Hirokazu Kawai,